Adenovirus-mediated delivery of antisense gene to urokinase-type plasminogen activator receptor suppresses glioma invasion and tumor growth

Cancer Research

Volumn 59, Issue 14, 1999, Pages 3369-3373

  Mohan, Pamarthi M ^a   Chintala, Shravan K ^a   Mohanam, Sanjeeva ^a   Gladson, Candece L ^b   Kim, Eui So ^a   Gokaslan, Ziya L ^a   Lakka, Sajani S ^a   Roth, Jack A ^a   Fang, Bingliang ^a   Sawaya, Raymond ^a   Kyritsis, Athanassios P ^a   Rao, Jasti S ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

UROKINASE; UROKINASE RECEPTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CANCER REGRESSION; GENE EXPRESSION; GENE TARGETING; GLIOMA; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION;

ADENOVIRIDAE; ANIMALS; BRAIN NEOPLASMS; DISEASE PROGRESSION; DNA, ANTISENSE; GENE THERAPY; GLIOBLASTOMA; HUMANS; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; ORGANOIDS; RATS; RECEPTORS, CELL SURFACE; TUMOR CELLS, CULTURED;

EID: 0033565613     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Mignatti, P., and Rifkin, D. B. Biology and biochemistry of proteinases in tumor invasion. Physiol. Rev., 73: 161-195, 1993.
2. Murphy, G., Atkinson, S., Ward, R., Gavrilovic, J., and Reynolds, J. J. The role of plasminogen activators in the regulation of connective tissue metalloproteinases. Ann. N. Y. Acad. Sci., 667: 1-12, 1992.
3. r 55,000 form of human plasminogen activator, urokinase. J. Cell Biol., 100: 86-92, 1985.
4. Pollanen, J., Stephens, R. W., and Vaheri, A. Directed plasminogen activation at the surface of normal and malignant cells. Adv. Cancer Res., 57: 273-328, 1991.
5. Roldan, A. L., Cubellis, M. V., Masucci, M. T., Behrendt, N., Lund, L. R., Dano, K., Appella, E., and Blasi, F. Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin-dependent proteolysis. EMBO J., 9: 467-474, 1990.
6. 2-terminal amino acid sequence and glycosylation variants. J. Biol. Chem., 265: 6453-6460, 1990.
7. Andreasen, P. A., Kjoller, L., Christensen, L., and Duffy, M. J. The urokinase-type plasminogen activator system in cancer metastasis: a review. Cancer (Phila.), 72: 1-22, 1997.
8. Crowley, C. W., Cohen, R. L., Lucas, B. K., Liu, G., Shuman, M. A., and Levinson, A. D. Prevention of metastasis by inhibition of urokinase receptor. Proc. Natl. Acad. Sci. USA, 90: 5021-5025, 1993.
9. Kook, Y. H., Adamski, J., Zelent, A., and Ossowski, L. The effect of antisense inhibitor of urokinase receptor in human squamous cell carcinoma on malignancy. EMBO J., 3: 3983-3991, 1994.
10. Yamamoto, M., Sawaya, R., Mohanam, S., Rao, V. H., Bruner, J. M., Nicolson, G. L., and Rao, J. S. Expression and localization of urokinase-type plasminogen activator receptor in human gliomas. Cancer Res., 54: 5016-5020, 1994.
11. Gladson, C. L., Pijuan-Thompson, V., Olman, M. A., Gillespie, G. Y., and Yacoub, I. Z. Upregulation of urokinase and urokinase receptor genes in malignant astrocytoma. Am. J. Pathol., 146: 1150-1160, 1995.
12. Yamamoto, M., Sawaya, R., Mohanam, S., Bindal, A. K., Bruner, J. M., Oka, K., Rao, V. H., Tomonaga, M., Nilcolson, G. L., and Rao, J. S. Expression and localization of urokinase-type plasminogen activator in human astrocytomas in vivo. Cancer Res., 54: 3656-3661, 1994.
13. Mohanam, S., Sawaya, R., McCutcheon, I., Ali-Osman, F., Boyd, D., and Rao, J. S. Modulation of in vitro invasion of human glioblastoma cells by urokinase-type plasminogen activator receptor antibody. Cancer Res., 53: 4143-4147, 1993.
14. Mohanam, S., Chintala, S. K., Go, Y., Bhattacharya, A., Venkaiab, B., Boyd, D., Gokaslan, Z. L., Sawaya, R., and Rao, J. S. In vitro inhibition of human glioblastoma cell line invasiveness by antisense uPA receptor. Oncogene, 14: 1351-1359, 1997.
15. Go, Y., Chintala, S. K., Mohanam, S., Gokaslan, Z., Venkaiah, B., Bjerkvig, R., Oka, K., Nicolson, G. L., Sawaya, R., and Rao, J. S. Inhibition of in vivo tumorigenicity and invasiveness of a human glioblastoma cell line transfected with antisense uPAR vectors. Clin. Exp. Metastasis, 15: 440-446, 1997.
16. Mohanam, S., Chintala, S. K., Mohan, P. M., Sawaya, R., Lagos, G. K., Gokaslan, Z. L., Kouraklis, G. P., and Rao, J. S. Increased invasion of neuroglioma cells transfected with urokinase plasminogen activator receptor cDNA. Int. J. Oncol., 13: 1285-1290, 1998.
17. Graham, F. L., and Prevec, L. Manipulation of Adenovirus Vectors. In: E. J. Murray (ed.), Methods in Molecular Biology, Vol. 7, pp. 109-127. Clifton, NJ: The Humana Press, 1991.
18. Kyritsis, A. P. Evaluation and treatment of CNS neoplasms. In: R. Lechtenberg and H. S. Schutta (eds.), Practice Guidelines for Neurologic Therapy, pp. 473-496. New York: Marcel Dekker, 1997.
19. Dear, A. E., and Metcalf, R. L. The urokinase-type-plasminogen-activator receptor (CD87) is a pleotrophic molecule. Eur. J. Biochem., 252: 185-193, 1998.
20. Ellis, V., Pyke, C., Eriksen, J., Solberg, H., and Dano, K. The urokinase receptor: involvement in cell-surface proteolysis and cancer invasion. Ann. N. Y. Acad. Sci., 667: 13-21, 1992.
21. Wei, Y., Lukashev, M., Simon, D. I., Bodary, S. C., Rosenberg, S., Doyle, M. V., and Chapman, H. A. Regulation of integrin function by the urokinase receptor. Science (Washington DC), 273: 1551-1555, 1996.
22. Sitrin, R. G., Todd, R. F, III, Albrecht, E., and Gyetko, M. R. The urokinase receptor (CD87) facilitates CDI1b/CD18-mediated adhesion of human monocytes. J. Clin. Invest., 97: 1942-1951, 1996.
23. Chapman, H. A. Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration. Curr. Opin. Cell Biol., 9: 714-724, 1997.
24. Ellis, V., and Dano, K. Potentiation of plasminogen activation by an anti-urokinase monoclonal antibody due to ternary complex formation. A mechanistic model for receptor mediated plasminogen activation. J. Biol. Chem., 268: 4806-4813, 1993.
25. Min, H. Y., Doyle, L. V., Vitt, C. R., Zandonella, C. L., Stratton-Thomas, J. R., Shuman, M. A., and Rosenberg, S. Urokinase receptor antagonists inhibit angiogenesis and primary tumor growth in syngeneic mice. Cancer Res., 56: 2428-2433, 1996.
26. Li, H., Lu, H., Griscelli, F., Opolon, P., Sun, L-Q., Ragot, T., Legrand, Y., Belin, D., Soria, J., Soria, C., Perricaudet, M., and Yeh, P. Adenovirus-mediated delivery of a uPA/uPAR antagonist suppresses angiogenesis-dependent tumor growth and dissemination in mice. Gene Ther., 5: 1105-1113, 1998.
27. Quattrone, A., Fibbi, G., Anichini, E., Pucci, M., Zamperini, A., Capaccioli, S., and Del Rosso, M. Reversion of the invasive phenotype of transformed human fibroblasts by anti-messenger oligonucleotide inhibition of urokinase receptor gene expression. Cancer Res., 55: 90-95, 1995.
28. Yu, W., Kim, J., and Ossowski, L. Reduction in surface urokinase receptor forces malignant cells into protracted state of dormancy. J. Cell Biol., 137: 767-777, 1997.
29. Bugge, T. H., Suh, T. T., Flick, M. J., Daugherty, C. C., Romer, J., Solberg, H., Ellis, V., Dano, K., and Degen, J. L. The receptor for urokinase-type plasminogen activator is not essential for mouse development or fertility. J. Biol. Chem., 270: 16886-16894, 1995.